Nicole Massie
Internal Medicine · Detroit, MINPI 1255536926
Payments from drug & device makers
Across 187 payments — averaging $30.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$994
- AbbVie$482
- GSK$476
- Lilly USA, LLC$342
- Abbott$335
- Biohaven Pharmaceuticals, Inc.$253
- plus $3K from 28 others
What the payments were for
- Food & beverage$5,645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $994 |
| AbbVie | 19 | $482 |
| GSK | 23 | $476 |
| Lilly USA, LLC | 16 | $342 |
| Abbott | 4 | $335 |
| Biohaven Pharmaceuticals, Inc. | 12 | $253 |
| Bayer | 4 | $189 |
| Alnylam Pharmaceuticals Inc. | 4 | $171 |
| Amgen | 3 | $169 |
| Aimmune Therapeutics, Inc. | 3 | $168 |
| Novartis | 4 | $151 |
| Amarin Pharma, Inc. | 1 | $145 |
| Exact Sciences | 7 | $140 |
| Novo Nordisk | 8 | $134 |
| Boston Scientific | 1 | $131 |
| Johnson & Johnson | 3 | $130 |
| Pfizer | 7 | $122 |
| Modernatx, Inc. | 1 | $121 |
| Astellas Pharma US Inc | 5 | $120 |
| Sanofi-aventis U.S. LLC | 7 | $118 |
| Abiomed | 2 | $113 |
| Sanofi Pasteur Inc. | 1 | $111 |
| Nestle Healthcare Nutrition Inc. | 8 | $110 |
| Teva Pharmaceuticals USA, Inc. | 3 | $79 |
| Biogen | 3 | $68 |
| Boehringer Ingelheim | 3 | $68 |
| Dexcom, Inc. | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Corcept Therapeutics | 1 | $26 |
| Medtronic | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Intuitive Surgical | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$350
- FreeStyle Libre 2$286
- BREZTRI$228
- Vascepa$145
- Kerendia$136
- WATCHMAN Access System$131
- Repatha$126
- ZENPEP$125
- UBRELVY$121
- Moderna Covid-19 Vaccine$121
- AREXVY$116
- XARELTO$115
- NURTEC ODT$114
- MOUNJARO$113
- AMVUTTRA$111
- FARXIGA$109
- ENTRESTO$102
How this compares
$5,645 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 90 | $63,157 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $62,482 |
| LinzessLinaclotide | 67 | $43,454 |
| FarxigaDapagliflozin Propanediol | 44 | $41,921 |
| OzempicSemaglutide | 34 | $33,939 |
| TrulicityDulaglutide | 28 | $31,803 |
| EliquisApixaban | 23 | $23,677 |
| EntrestoSacubitril/Valsartan | 15 | $21,499 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $19,195 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $13,492 |
| MounjaroTirzepatide | 11 | $11,242 |
| RybelsusSemaglutide | 11 | $10,010 |
| JanuviaSitagliptin Phosphate | 14 | $9,194 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $8,196 |
| XareltoRivaroxaban | 12 | $7,607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $68 | $63,15790 claims |
| GSKTrelegy Ellipta | $476 | $62,48276 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $994 | $61,11674 claims |
| Novo NordiskOzempic, Rybelsus | $134 | $43,95045 claims |
| AbbVieLinzess | $482 | $43,45467 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $342 | $43,04539 claims |
| PfizerEliquis | $122 | $23,67723 claims |
| NovartisEntresto | $151 | $21,49915 claims |
| Johnson & JohnsonXarelto | $130 | $7,60712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Detroit
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Rana BalboulDetroit$2.4M
- Philip KuriakoseDetroit$1.9M
- Erlene SeymourDetroit$797K
- Sheela TejwaniDetroit$712K
- Vrushali DabakDetroit$509K
- James McCordDetroit$493K
- Saroj NeupaneDetroit$487K
- David StocktonDetroit$402K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.